Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Tacrolimus and its derivativesF1 I SEP / 98
TalbutalC2 I JUN / 02
Taliglucerase alfaPDL I JUL / 14
Tamoxifen and its saltsF1 I SEP / 98
Tamsulosin and its saltsF1 I SEP / 99
TapentadolN (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-phenol), its salts, derivatives and isomers and salts of derivatives and isomers I JAN / 16
TazaroteneF1 I SEP / 98
Tazobactam and its salts and derivativesF1 I SEP / 98
Tedizolid or its salts or derivativesPDL

including but not limited to Tedizolid phosphate

I MAY / 15
TeduglutidePDL I OCT / 15
Tegafur and its saltsF1 I JUL / 03
Tegaserod and its saltsF1 I MAY / 04
Telaprevir or its derivativesPDL I DEC / 13
TelbivudineF1 I MAY / 09
Telithromycin and its salts and derivativesF1 I JUN / 06
Telmisartan and its salts and derivativesF1 I MAR / 01
Temazepam and its saltsTS I SEP / 98
Temozolomide and its saltsF1 I MAR / 01
TeniposideF1 I SEP / 98
Tenofovir and its salts and derivativesF1 I JUN / 06
Tenoxicam and its saltsF1 I SEP / 98
Terazosin and its saltsF1 I SEP / 98
Terbinafine and its saltsF1 I SEP / 98
Terbutaline and its saltsF1 I SEP / 98
Terconazole and its saltsF1 I SEP / 98
Terfenadine and its saltsF1 I SEP / 98
Teriparatide and its saltsF1 I APR / 07
Terlipressin and its saltsF1 I SEP / 98
Tesamorelin or its salts or derivativesPDL I MAY / 14
TestosteroneC3 I JUN / 02
Tetanus immune globulin I FEB / 02
Tetanus toxoid II DEC / 98
Tetrabenazine and its saltsF1 I SEP / 98
TetracainePDL

when in a preparation containing an equal amount of lidocaine and recommended for topical use on the skin, in concentrations of 7% or higher

I FEB / 14
Tetracaine and its salts

for ophthalmic or parenteral use

II SEP / 98
Tetracaine and its salts for topical use on mucous membranes, except lozenges III SEP / 98
Tetracycline and its salts and derivativesF2 except doxycycline when sold for intramuscular administration in caged birds I SEP / 98
Tetrahydrozoline in nasal preparations for pediatric use II SEP / 98
Tetrahydrozoline. for ophthalmic use and in nasal preparations for adults U
TetrazepamTS I JUN / 02
Tezacaftor or its saltsPDL I JUL / 18
ThalidomideF1 I SEP / 98
ThebaconN I JUN / 02
Thebaine (paramorphine)N I JUN / 02
Theophylline and its saltsF1 I SEP / 98
ThiabendazoleF2 I SEP / 98
ThialbarbitalC2 I JUN / 02
ThiamylalC2 I JUN / 02
Thiethylperazine and its saltsF1 I SEP / 98
Thiobarbituric AcidC2 I JUN / 02
ThiocarlideF1 I SEP / 98
ThiofentanylN I JUN / 02
ThioguanineF1 I SEP / 98
ThiopentalC2 I JUN / 02
Thiopropazate and its saltsF1 I SEP / 98
Thioproperazine and its saltsF1 I SEP / 98
Thioridazine and its saltsF1 I SEP / 98
ThiotepaF1 I SEP / 98
Thiothixene and its saltsF1 I SEP / 98
Thiouracil and its derivativesF1 I SEP / 98
Thrombin II SEP / 98
Thyroglobulin II SEP / 98
ThyroidF2 I SEP / 98
Thyrotropin II SEP / 98
Thyrotropin alfaF1 I MAY / 04
Thyroxin and its saltsF1 I SEP / 98
Tiaprofenic acid and its saltsF1 I SEP / 98
TiboloneC3 I JUN / 02
Ticagrelor or its derivativesPDL I DEC / 13
Ticlopidine and its saltsF1 I SEP / 98
TigecyclineF1 I APR / 08
TildipirosinPDL

for veterinary use

I DEC / 14
Tilidine and its salts, derivatives and salts of derivativesN I JUN / 02
TilmicosinF1 I SEP / 98
Tiludronic acid and its saltsF1 I SEP / 98
Timolol and its saltsF1 I SEP / 98
TinidazoleF1 I SEP / 98
Tinzaparin and its saltsF1 I SEP / 98
Tioconazole and its saltsF1

except in preparations for topical or vaginal use in humans

I SEP / 98
Tioconazole and its salts.F2 I SEP / 98
Tioconazole and its salts.. in preparations for intra-vaginal use III OCT / 98
Tioconazole and its salts... in preparations for topical use U OCT / 98
TiomesteroneC3 I JUN / 02
Tiotropium bromideF1 I MAY / 04
Tipiracil or its saltsPDL I MAR / 18
Tipranavir and its saltsF1 I FEB / 07
Tirofiban and its salts and derivativesF1 I MAR / 01
Tizanidine and its saltsF1 I SEP / 99
Tobramycin and its salts and derivativesF1 I SEP / 98
Tocainide and its saltsF1 I SEP / 98
TocilizumabFR I APR / 10
Tofacitinib or its saltsPDL I MAY / 14
TolazamideF1 I SEP / 98
Tolazoline and its saltsF1 I SEP / 98
TolbutamideF1 I SEP / 98
TolcaponeF1 I SEP / 99
Tolfenamic acid and its salts and derivativesF1 I MAY / 04
Tolmetin and its saltsF1 I SEP / 98
Tolterodine and its saltsF1 I SEP / 99
Tolvaptan or its derivativesPDL I DEC / 13

154 résultats


Footnotes

  • C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations}
  • C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
  • C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
  • C4: drug is in the Controlled Drugs and Substances Act
  • C5: drug is in the Regulations Under CDSA
  • CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
  • CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
  • CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
  • CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
  • F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
  • F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
  • FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
  • N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
  • NR: drug has not been reviewed by NDSAC
  • PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
  • R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
  • TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
  • U: drug has been reviewed by NDSAC and is unscheduled